Nectar Lifesciences manufacturing unit gets US FDA nod

Moneycontrol Bureau

Nectar Lifesciences has received US Food and Drugs Administration (FDA) approval for its Active Pharmaceutical Ingredients (API) manufacturing plant Unit-II in Dera Bassi, Punjab. Nectar Lifesciences hit the 20% upper circuit at Rs 23 on NSE post the announcement in afternoon trade. This facility has also been approved by Japan